relative to treatment alternatives to opioids.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 10 Sponsors 3

Tom Dolan
Cosponsor · House · District Rockingham 16 R Dave Nagel
Primary · House · District Belknap 6 D Bill Palmer
Cosponsor · House · District Sullivan 2 D

PASSAGE PROBABILITY

38.9% Uncertain

Why this number

Stage base Reported from Committee — base rate 47%, measured from NH's completed sessions
Momentum -0 49/100 from the pace of recorded action
Time since last action -22 334 days quiet
Cosponsors +3 2 signed on
Bipartisan support +9 2 D · 1 R
Sponsor influence +2 71/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.